Skip to main content Skip to main navigation


Accelerating Innovations for Enhanced Brain Health. Can Artificial Intelligence Advance New Pathways for Drug Discovery for Alzheimer’s and other Neurodegenerative Disorders?

A. S. Khachaturian; Andreas Dengel; V. Dočkal; P. Hroboň; M. Tolar
In: The Journal of Prevention of Alzheimer's Disease (JPAD), Vol. 10, No. 1, Pages 1-4, Editorial initiative of the Clinical Trials on Alzheimer's Desease Conference, 1/2023.


Artificial intelligence/machine learning (AI/ML) offers new solutions to untangle the complexity involved in discovery of new intervention targets for neurodegenerative disorders

Weitere Links